Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 8/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 8/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11117641 | 0.98 | GNAI3 (0.43) | SIGMAR1GNAI3GNAO1GNAI1GPR84 | |
| SCHEMBL21581265 | 0.98 | GNAI3 (0.43) | SIGMAR1GNAI3GNAO1GNAI1GPR84 | |
| SCHEMBL1409000 | 0.94 | SIGMAR1 (0.47) | SIGMAR1GNAI3GNAO1GNAI1 | |
| SCHEMBL27862639 | 0.87 | GNAI3 (0.38) | SIGMAR1GNAI3GNAO1GNAI1GPR84 | |
| SCHEMBL1408997 | 0.86 | SIGMAR1 (0.39) | SIGMAR1GNAI3GNAO1GNAI1 | |
| SCHEMBL3932573 | 0.86 | GPR84 (0.40) | GPR84SPHK1FFAR1LMNA | |
| SCHEMBL21581300 | 0.85 | LMNA (0.38) | SIGMAR1GNAI3GNAO1GNAI1GPR84 | |
| Hydrochloric Acid SCHEMBL6956666 | 0.84 | SIGMAR1 (0.38) | SIGMAR1GNAI3GNAO1GNAI1 | |
| Methane SCHEMBL2871267 | 0.84 | SIGMAR1 (0.38) | SIGMAR1GNAI3GNAO1GNAI1 | |
| SCHEMBL8972636 | 0.84 | GPR84 (0.43) | GPR84SPHK1FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2295438-B2 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023071601-A1 | DESLORATADINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 天津市昕晨投资发展有限公司 | 2023-05-04 | — | — | WO | disclosed |
| EP-3575289-B1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | TOSOH CORP (JP) | 2023-04-19 | — | — | EP | disclosed |
| CN-115385892-A | Desloratadine derivative, preparation method and application thereof | 天津市昕晨投资发展有限公司 | 2022-11-25 | — | — | CN | disclosed |
| US-10927084-B2 | Alkanolamine, friction-reducing agent, and lubricating oil composition | TOSOH CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| US-20200039942-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | TOSOH CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3575289-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | Tosoh Corporation (JP) | 2019-12-04 | — | — | EP | disclosed |
| WO-2017030814-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS | Arvinas, Inc. (US) | 2017-02-23 | — | — | WO | disclosed |
| EP-2295438-B1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2015-03-18 | — | — | EP | disclosed |
| US-20110077376-A1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING IT | TOSOH CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-2295438-A1 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | Tosoh Corporation (JP) | 2011-03-16 | — | — | EP | disclosed |
| US-4455168-A | CONTAINING A HETEROCYCLIC, HYDROXY AMINE OR AMIDE | RICOH COMPANY, LTD. (JP) | 1984-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039942-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | APOB, HRH3, PHOSPHO1 | SIGMAR1 25/4885GNAI3 3257/4885GNAO1 2390/4885 |
| US-10927084-B2 | Alkanolamine, friction-reducing agent, and lubricating oil composition | APOB, HRH3, PHOSPHO1 | SIGMAR1 25/4885GNAI3 3257/4885GNAO1 2390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.